Dosing & Administration
This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published rese…
The trial schedules, and why you cannot buy it
This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published research. It is not a protocol or a recommendation, and amycretin is not legally available outside a Novo Nordisk clinical trial.
The honest throughline: the only real dosing information comes from the trials, both formulations climb the dose slowly, and any "research peptide" amycretin sold online is unverified and not legally compoundable.
Key terms
The trial-validated schedules
The only legitimate dosing information for amycretin comes from its trials, and it is presented here as research context, not a prescription. The two formulations differ: the oral tablet is once daily (using the SNAC platform), the subcutaneous injection is once weekly, and both use slow up-titration.
Two points matter most. First, the optimal maintenance dose is not yet established, because these were dose-finding trials, not confirmatory ones. Second, these figures describe a quality-controlled trial product delivered under medical supervision, not a number anyone should act on with an online vial.
This unit is education only and not medical advice. The trial regimens are research reference information, not a recommendation to use amycretin.